Experts at Yale Cancer Center highlight ongoing trials intended to improve outcomes across mantle cell lymphoma, T-cell lymphoma, and other populations.
Tarsheen Sethi, MD, MSc
Advertisement
Articles by Tarsheen Sethi, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5